Stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days and starting within 48 hours of stroke symptoms, had better recovery than patients who ...
The most common side effects of IV lecanemab are headache, infusion-related reactions, and amyloid-related imaging abnormalities, a side effect known to occur with the class of an ...
FDA clears subcutaneous Sarclisa Escena for multiple myeloma, showing comparable overall response rates to IV delivery.
Morning Overview on MSN
Multiple myeloma patients can now get the drug Sarclisa as a quick under-the-skin shot
People living with relapsed or refractory multiple myeloma now have a faster way to receive one of their key treatments. The ...
The FDA has approved a subcutaneous version of isatuximab (Sarclisa Escena, Sanofi-Aventis) for several multiple myeloma (MM) ...
Joseph Mikhael, MD, MEd, highlights the clinical and logistical advantages of the novel on-body injector developed for the ...
Affirmative therapy, or LGBTQ+ affirmative therapy, is a therapeutic approach that validates and advocates for the needs of sexual and gender minority individuals. Affirmative therapy employs a ...
Nicotinamide adenine dinucleotide (NAD) and its reduced form (NADH) therapy are dietary supplements that are promoted widely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results